This document summarizes a noon conference on hemolytic anemia. It discusses the presentation, diagnostic approach, and treatment of drug-induced hemolytic anemia specifically. Key points include that drug-induced anemia can be oxidative or immune-mediated, with oxidative stress converting hemoglobin to methemoglobin. Phenazopyridine is highlighted as a common culprit that can cause both hemolysis and acute renal failure. Methemoglobinemia is also covered, noting symptoms of cyanosis and dark blood despite normal oxygen levels. Treatment depends on methemoglobin percentage and G6PD deficiency status, using methylene blue or ascorbic acid as indicated.